These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 8804792)

  • 1. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Masaru Y; Otani T; Hyodo A; Hiramatsu K
    Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Lozniewski A; Lion C; Mory F; Weber M
    J Antimicrob Chemother; 2001 Jan; 47(1):83-6. PubMed ID: 11152435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalis.
    Nomura S; Hanaki H; Furukawa T; Unemi N
    Chemotherapy; 1996; 42(6):432-8. PubMed ID: 8957577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Smith KR; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
    Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
    Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
    Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):362-6. PubMed ID: 8834881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
    Fosse T; David MF; Duluc F
    Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of TOC-50, a new parenteral cephalosporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Nomura S; Hanaki H; Furukawa T; Unemi N
    Chemotherapy; 1997; 43(1):1-5. PubMed ID: 8996734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of vancomycin and other antimicrobial agents against methicillin-resistant staphylococcus aureus and enterococcus faecium in the Tohoku district of Japan.
    Lutfor AB; Kikuchi T; Tokue Y; Takahashi H; Shoji S; Fujimura S; Nukiwa T; Watanabe A
    Chemotherapy; 1998; 44(5):318-23. PubMed ID: 9732146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
    Miyake N; Kadowaki M; Sato Y; Eriguchi Y; Nagasaki Y; Harada Y; Uchida Y; Shimono N
    Jpn J Antibiot; 2011 Aug; 64(4):231-7. PubMed ID: 22066347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.
    Salem AH; Elkhatib WF; Ahmed GF; Noreddin AM
    J Chemother; 2010 Aug; 22(4):238-42. PubMed ID: 20685626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between methicillin-resistance and resistance to fluoroquinolones in Staphylococcus aureus and Staphylococcus epidermidis].
    Cafiso V; Campanile F; Borbone S; Caia A; Cascone C; Santagati M; Stefani S
    Infez Med; 2001 Jun; 9(2):90-7. PubMed ID: 12698021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Lemaire S; Olivier A; Van Bambeke F; Tulkens PM; Appelbaum PC; Glupczynski Y
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2797-805. PubMed ID: 18519727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.